Vynleads (VYND) 10-K 21 Mar 23 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 21, 2023	Jun. 30, 2022
Entity Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	333-227499
Entity Registrant Name	Vynleads, Inc.
Entity Central Index Key	0001745078
Entity Tax Identification Number	47-4584272
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	596 Herrons Ferry Road
Entity Address, Address Line Two	Suite 301
Entity Address, City or Town	Rock Hill
Entity Address, State or Province	SC
Entity Address, Postal Zip Code	29730
City Area Code	(845)
Local Phone Number	745-0981
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 0
Entity Common Stock, Shares Outstanding		11,599,830
Auditor Name	Assurance Dimensions
Auditor Location	Margate, Florida
Auditor Firm ID	5036
Liggett Webb [Member]
Entity Information [Line Items]
Auditor Name	Liggett & Webb, P.A.
Auditor Location	Boynton Beach, Florida
Auditor Firm ID	287

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 503	$ 1,716
Accounts Receivable
Holdback Receivable from merchant, net of reserve for refunds of $58 and $58, respectively	15,764	15,764
Prepaid Expenses and other current assets	8,061	7,910
Total current assets	24,328	25,390
Total assets	24,328	25,390
Current Liabilities:
Accounts payable and accrued expenses	290,788	267,006
Notes Payable	354,029	235,250
Notes Payable – Related Party	15,000	15,000
Total current liabilities	659,817	517,256
Total liabilities	659,817	517,256
Commitments and contingencies (See Note 8)
Stockholders' deficit:
Preferred stock; $0.0001 par value; 5,000,000 shares authorized, no shares issued and outstanding, respectively
Common stock; $0.0001 par value; 50,000,000 shares authorized; 11,599,830 shares issued and outstanding	1,160	1,160
Additional paid-in capital	1,624,252	1,494,252
Accumulated deficit	(2,260,901)	(1,987,278)
Total stockholders' deficit	(635,489)	(491,866)
Total liabilities and stockholders' deficit	$ 24,328	$ 25,390

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Refunds	$ 58	$ 58
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	11,599,830	11,599,830
Common stock, shares outstanding	11,599,830	11,599,830

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue, net of refunds and chargebacks	$ 49	$ 484
Cost and Expenses:
Cost of Revenue	29,197	32,467
Gross Loss	(29,148)	(31,983)
Operating Expense
Selling, general and administrative expense	232,100	234,790
Total costs and expenses	232,100	234,790
Loss from operations	(261,248)	(266,773)
Other income(expense)
Gain on partial PPP Loan Forgiveness	3,700	6,250
Interest expense	(13,570)	(11,058)
Net loss before provision for income taxes	(271,118)	(271,581)
State Income tax expense	(2,505)
Net loss	$ (273,623)	$ (271,581)
Net loss per common share, basic	$ (0.01)	$ (0.02)
Net loss per common share, diluted	$ (0.01)	$ (0.02)
Weighted average common shares outstanding, basic	11,599,830	11,596,431
Weighted average common shares outstanding, diluted	11,599,830	11,596,431

Statements of Stockholders' Def

Statements of Stockholders' Deficit - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 1,160	$ 1,364,252	$ (1,715,697)	$ (350,285)
Beginning balance, shares at Dec. 31, 2020	11,599,830
In Kind Contribution of Services		130,000		130,000
Net Loss			(271,581)	(271,581)
Ending balance, value at Dec. 31, 2021	$ 1,160	1,494,252	(1,987,278)	(491,866)
Ending balance, shares at Dec. 31, 2021	11,599,830
In Kind Contribution of Services		130,000		130,000
Net Loss			(273,623)	(273,623)
Ending balance, value at Dec. 31, 2022	$ 1,160	$ 1,624,252	$ (2,260,901)	$ (635,489)

Statement of Cash Flows

Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (273,623)	$ (271,581)
Adjustments to reconcile net loss to net cash flows used in operating activities
In Kind Contribution of Services	130,000	130,000
PPP Courtesy Credit	(3,700)	(6,250)
Changes in operating assets and liabilities and other, net	23,631	17,318
Net cash flows used in operating activities	(123,692)	(130,513)
Cash flows from financing activities:
Proceeds from notes payable	125,000	120,000
Proceeds from notes payable – related party		15,000
Repayment of notes payable	(2,521)	(10,000)
Net cash flows provided by financing activities	122,479	125,000
Net decrease in cash	(1,213)	(5,513)
Cash at beginning of year	1,716	7,229
Cash at end of year	503	1,716
Supplemental disclosure of cash flow information:
Income taxes paid	2,505
Interest paid	$ 13,570	$ 3,226

Business

Business	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business	1. Business Vy n ea d n c (“Vynl e ads” wa i n c orporat e a Delawar c orporatio o Jul 1 5 2015 W ar provide o healt a n wellnes informatio principally targete t p e opl wh ar p e diab e e o wh hav typ d ia b s W p o d o c ustomer wh ar s e eki n t mak h ealth choice by o d n e r ints e ducati o n resources an supp o rt Ou c r pro d c i ou roprietar Lifestyl Blu e ri n t digi a gu d tha p o d e dietar recommendati o fo v e l l ri e t-w e o gethe wi infor atio o cusi n o what ho an ho muc perso eats nutritio n al informatio an h o person’ d o o e o t enabl ou customer t continu lea d in mor suc c essfu ifestyle W als offer nutritio n a supplement a n month l u bscription t ou propr etar newslette whic cover wid v a iet o a -relate topics. Ou corporat h eadquarter ar locate i R o c Hill S out Caro

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	2. Going Concern Our fin a a h b ee presente o e n basis h n emplate th rea izatio o asset an satis ac io of iabi it e i th norma cou s o bus n es Sinc Ju 15 2 15 th dat o ou nc e tion w hav exp e ienc e recurrin op a n e operatin cas fl o s a n h a financ e o u recen workin capita requirement prim a il throu g th issua n c o deb D u in th y ear en d e Decemb e 31 2 022 an 2021 w hav reporte n e losse o $ 273,623 $ 271,581 respectiv e y. A o Decembe 31 2 022 ou w o r k n capita defici wa $ 635,489 ou accumulate d e 2,260,901 h operations 123,692 e u e e n beli e e tha ther i substantia doub abou o u abilit t co n inu a goin con c er n Despit o u curren a es e x pense cas flo projecti o ns an aggregat cas an holdback re c eiv a l fro o u merchant ne o reserv f o refunds o $ 15,764 wil requir u sta n tia fun d t e xpan servi c a n pro d uc n a a e a mar k e an promot o servic a p o develo an gro ou i n rastructur an corp o a organizati o n Ou ca p ita requirement d e pen o numerou fac t ors includin bu no im te t u abil ty t generat suf icien rev e nue t pa ou operatin ex p enses. Ou abilit t mee ou curren an projecte oblig a ion depen d o ou abilit t generat s fficien sale a n t contro e e q h e a c a g r ivat and/o pu b li fina n cin sources Ther ca b n a s u ance tha w wil ac h iev ou forecaste financia result o t h at w l b abl rais add tiona c a pita t operat o u bus i ness An suc failur wo u l hav e i d o o u liq u idit a n financial conditio an coul forc u t c u rtai o disc o ntinu op e rati n entirel a n c oul req u ir u t fil fo pr tectio un d e a k u c laws e c n ti a d u abilit t continu a goin concern. The financial statements do not include any adjustments that might result from the outcome from this uncertainty.

Summary of Critical Accounting

Summary of Critical Accounting Policies	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Critical Accounting Policies	3. Summary of Critical Accounting Policies Accounting Principles The financial statements and accompanying notes are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Use of Accounting Estimates The preparati o a a tement i conformit wit U.S GAA requ re a nagemen t mak cer ai est mate an assumption tha aff e c the re p rte amount o asset a n liabilitie an di c losur o cont gen asset an liab li ie a th dat o h financia s t atement an th re p rte amount of re v enu an expense durin th reporti n p e iod W believ t a judg e me n i involve n ou reserv fo refunds o holdb a ck reserv e o stock-base compe sation. W evaluat o u estimates an as u m p tion a fact a n c rcumstance di c tate A utur event a n thei e fect canno b e p e c tua result c oul diffe from thes estimate an assum p tions a n thos differen c e co u b ma e ia t h F anc a Sta e en s. Cash C as nc u e c a an dep o ite a on are ban an ma excee federall insure limit a n s i ghl liqui investment wit t ri re m t o les whe purchase t b c as e q u v a e n s T car y am n e porte i th balanc sheet o cas an cas equivalents approximat thei fai value. Holdback Receivable Holdba c receiva b include m rchan holdbac ne o e e r v fo r e urns whic reser v i $ 58 $ 58 a c e b e 31 2022 an 2021, es p ectively. Revenue Recognition The Company accounts for revenue in accordance with Accounting Standard Codification (“ASC”) We generate revenues primarily from (i) internet content subscriptions and (ii) sales of nutritional supplements. Revenues are recognized upon the acceptance of subscription membership or shipment of nutritional supplements, provided that an order has been received or a contract executed, there are no uncertainties regarding customer acceptance, the sales price is fixed or determinable and collection is deemed reasonably assured. If uncertainties regarding customer acceptance exist, we recognize revenues when those uncertainties are resolved, and title has been transferred to the customer. Amounts collected or billed prior to satisfying the above revenue recognition criteria are recorded as deferred revenue. Ou percentage o rev e nu b typ fo y ear en d e Decemb e 31 2 022 an 2021 ar a follows: Percentage of Revenue by Type Year ended December 31, 2022 2021 Internet content subscriptions 0.0 % 0.0 % Nutritional supplements 100.0 % 100.0 % Shipping and Handling Costs We include shipping and handling fees billed to customers as revenue and shipping and handling costs for shipments to customers as cost of revenue. Loss Per Share Basi los pe c o mo shar compute b di v din ne los b th weighted-averag numbe o commo share o utstandin durin th period Dilute loss pe commo shar i base upo t weighted-avera g commo share out tan d n durin t h perio plu a d itiona weighted-aver g commo equivalent h are outstandin duri n th per o Commo eq u iv a en share resul fro th assume exerci d n an warrants th proce e d of whic ar the assume t h a b ee use t repurchas outst a d n o n a u e o a th numerato i a d juste for an change i incom (loss th a o u resul fro th assume c onversio o potenti a shares Potentiall dilutiv h ares h c wer e cl u e ro t h d lute s pe sha calculat o be c aus th effec woul b a o n w arrant ex e cis pric e wer g e a te t h a th averag market pric o th commo shares wer 585,766 s a f t r e nde D e cembe 3 1 2022 an 2021. Income Taxes Th provisio fo inc o taxe i nc u d e federal stat e l o ca an foreig taxes In c om taxe ar a ccounte fo un d e th liabi it ethod e erre ta a sets an liabiliti e ar r e cognize fo th estimate futur ta co n e quence o temporar differen c e betwee t h financia statemen carryin amount an their es p ec iv ta b ases. Deferre t a asset a n liabilitie ar me a u e usin enacte ta rate expecte t ap p t t axa b l incom i t y i hic th temporar di feren c e are expecte t b recovere o se tled W evaluat t h realizabi it o ou deferr e ta asset a n establis va u o an c whe i i mor likel tha not a a o port o deferre ta asset wi no b rea ize d W accoun f o unc e tai ta posi ion usin “more-li k ely-tha h e h c n a n resolvin uncertai ta positions T evaluatio of uncertai ta position i base c n d g o imi e to change i a law h measuremen o ta posi io k e o e a returns h effectiv sett e e n o matter subjec t audit ne aud ac ivit an change i fact o circ u mstance re a W v u a thi ta positio o quart e l basis W al ac c fo pot e n ia interes an pena ties applicable re a e t u nrecog b t i incom tax expense. Stock-Based Compensation We account for stock based instruments issued to employees and non-employees for services in accordance with Accounting Standard Codification (“ASC”) Topic 718. St o ck-base compensatio i me a s e a e v u h awar an i recognize a a e xpens ove th requisite e v Accordingly th Black-Sch o e opti o pricin m o de i utilize t d e riv a estimate fai v u e Th Black- S chole pricin mo d e require th consideratio o h foll o win si variable fo purpose o estimatin f a i val u e: · the stock option exercise price; · the expected term of the option; · the grant date price of our common stock, which is issuable upon exercise of the option; · the expected volatility of our common stock; · the expected dividends on our common stock (we do not anticipate paying dividends in the foreseeable future); and · the risk-free interest rate for the expected option term. Expe c ed Di v ide n ds W hav nev e declare o p a i an cas divi d end o a n o ou capita s c n i th foresee a b future. Acc o d in g y w us a expecte divid e n y el o z e t c al cu at h ran - at a valu o stoc option. Expe c ed Volatility Th expecte volatilit i m e asur o t h u o p i c i exp e cte t luctuat dur n th expecte ter o o ptions g a t e d W determin th expec t e volatilit solel base up o th hi torica o ati it ou comm o stoc ove p erio c o mmensurat wit th opti o n’s expecte term W d no belie v tha th futu volati it ou comm o stoc ove a option’ expecte te i lik e t diffe signif c a n l f th pas Risk-Free Interest Rate . Th risk- re in e es a i th m li e yiel availa b l o U.S reasur zero-coupo issue wit remainin ter equ a t the option’ expecte te o t h gra n date. Expe c ed Term F o optio grant subseq u n t th ado p tio o th fai valu re c ognitio provis o h c n rds th expe c e lif o stock option grante i base o t h actua vestin dat an th en o th co n ractua term. Gr a Date Price of Common S o c h a e c o h a g a n Fair Value of Financial Instruments W o llo Acco u tin Standard Co d ficatio 82 0 - 1 (“AS 8 20-1 0 “Fai r V a lu Measur e e n t an Disclosures, fo a valu measurements AS 8 2 0- 1 d efine fai value establis h e fr a e or fo measurin f i value an exp a nd d isclosu r e a bou fai v a lu measurements T h standar provide consi ten def it o fa value whic f o cuse o a exi price whic i t h p r ic th a woul b receive t sel a asse o pai t t a n s e liabilit i an d e a etw a k e rt ipant a th mea u e m e n date T h standar als p ioritizes withi t h measuremen o fai alue h us of mark e -base inform a tio ove en t it p ecifi informati o a n e stabli h e three-le v e hierarch f o fai valu m e asuremen base o th n at u o in p ts h a a e o l ab l t a o th mea u r e e n date. Th hierarch establishe unde A S 820-1 give th highes priorit t u n adjuste qu o te pri v d i ca asset o liabilitie (Leve 1) an th lowes pri o it t unobserv a bl input (Leve 3) Th hre level o t h fai v a u hierarch unde A S 820-1 ar de e e Leve Pri c in input ar quo t e price a v ailabl i activ market o ident ca n ves ment h o e require b AS 8 20-10 we d n adjus th quote pric f o thes investm e nts e ve i s t ati w er w h a g o it o an sal c o reas n a bl impac th quoted Leve Pri c in input ar quo t e price fo simila i n estme n s o i n put tha ar observable eithe d rectl ind rec ly fo subs an ial th ll ter throu g c o rro b or a io wit observabl marke data Le v e nc de investment value a q uot e price adjuste fo leg a o r t estri c ion speci i t s n s m ts Leve Pri c in input ar uno b ser v abl fo th investment t a s i u h a ref c h re rti e it ’ w ass m i on abou t h assumptions mark e participant wo u us i pric n th asse o iabil t Leve include inv e tment a o a c y The carrying a u o sh holdbac receivable prepaid expense and other current asset, ac c ount pa y abl an ac c e e x ense approx i mat thei fai value du to thei s h ort-ter matu iti e a o Decembe 31 2 022 a n 2 021. Recent Accounting Pronouncements We have evaluated all issued but not yet effective accounting pronouncements and determined that, other than the following, they are either immaterial or not relevant to us.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions On March 16, 2021, the Company executed a note payable to Mr. Sergei Stetsenko, a member of our Board of Directors, in the amount of $ 15,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 1,336 On June 14, 2018, we entered into an employment agreement with Mr. Mannine pursuant to which he was engaged to serve as our Chief Executive Officer. Mr. Mannine’s compensation includes a grant of 10 100,000 0.225 On September 21, 2020, Mr. Mannine voluntarily agreed to cancel the employment agreement and waive all cash due and any related accruals. During the years ended December 31, 2022 and 2021, $ 130,000 130,000 On May 21, 2018, we entered into an Amended and Restated Strategic Financing & Corporate Development Agreement with CRG which was amended and restated an earlier agreement entered into in October 2017. We have engaged this company to serve as our non-exclusive strategic financing and corporate development services provider and to render certain advice and services to us as we may reasonably request concerning equity or debt financings, strategic planning, merger and acquisition possibilities, and business development activities. The scope of services under this agreement also includes introducing us to one or more non-U.S. persons, as that term is defined in Regulation S under the Securities Act, in connection with possible debt or equity financings or potential lenders. The initial term of the agreement expired in May 2020, but pursuant to the terms of the agreement, renews automatically for one-year periods unless notice of non-renewal is provided by either party at least 30 days prior to the renewal term commencement. The agreement was renewed until May 2023. As compensation under the terms of this agreement, we agreed to pay CRG Finance AG certain fees for transactions which are consummated during the term of the agreement and for a one year period following the termination of the agreement, including: · a fee equal to 7% of the proceeds received by us plus a warrant exercisable into 7% of the shares of our common stock at the offering price of our shares for sales by us of equity or equity-linked securities to non-U.S. Persons introduced to us by CRG Finance AG; · a fee equal to 1% of the total gross cash proceeds or non-cash consideration received by us, together with a five year warrant exercisable into 1% of the securities issued or to be issued by us in a business combination with a non-U.S. person first introduced to us by CRG Finance AG; · a fee equal to 1% of consideration received by us in any debt financing not convertible into equity, including, but not limited to, a revolving credit line or credit enhancement instrument, including on an insured or guarantee basis, with a non-U.S. Person first introduced to us by CRG Finance AG; and · a fee equal to 2% of any revenue-producing contract, fee-sharing arrangement, licensing, royalty or similar agreement with a non-U.S. Person first introduced to us by CRG Finance AG. In addition to the foregoing fees, we have agreed to reimburse CRG Finance AG for its pre-approved out of pocket expenses it incurs under the terms of the agreement. The agreement contains customary confidentiality and indemnification provisions.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	5. Income Taxes Fo th yea ende Decembe 3 1 2022 th provisio fo incom taxe wa $ 2,505 F o th y ea e n d c b e h 0 Deferre ta asset hav bee reduce t a amou n deeme recoverabl fr o th u s o l o s carrybac k A o Decembe 31 2 022 w h av ne operatin los carryforward o a pproxim a tel $ 1.8 million O u n e operatin los carryfo r ward wil b subjec to annua lim tat o n s a discusse abov e w h c co u reduc o efe th utili z atio o th losse a resul o a ownershi n a e c th Interna Revenu Code Net operating losses of approximately $1.39 million may be carried forward indefinitely subject to limitation. Net operating losses of approximately $407,000 will begin expiring in 2037. Income taxes amounted to less than the amounts computed by applying the U.S. Federal income tax rate of 21% to income (loss) before income taxes. Income Tax Rate Reconciliation 2022 2021 Tax Rate Tax Rate Taxes computed at statutory rate Federal $ (57,117 ) 21.00 % $ (57,032 ) 21.00 % State (9,160 ) 3.95 % (10,727 ) 3.95 % Total taxes at blended statutory rate $ (66,277 ) 24.95 % $ (67,759 ) 24.95 % Increase (decrease) resulting from: Effect of tax rate change — 0.00 % — 0.00 % Nondeductible expenses 31,581 0.00 % — 0.00 % State income tax refund — 0.00 % — 0.00 % Other — -0.14 % 385 -0.14 % Change in valuation allowance 36,336 -24.81 % 67,374 -24.81 % Total income tax (benefit) expense $ 1,640 -0.00 % $ (0 ) -0.00 % The tax effect of significant components of our deferred tax assets and liabilities at December 31, 2022 and 2021 Deferred Tax Assets and Liabilities 2022 2021 Deferred tax assets: Net operating loss carryforward $ 423,025 $ 509,707 Amortization of intangibles 7,936 7,485 Reserve for refunds 0 15 Stock compensation 3,774 3,774 Charitable contribution carryforward 3,355 3,355 Total deferred tax assets 438,090 524,337 Less: Valuation allowance (438,090 ) (524,337 ) Net deferred tax assets $ — $ — In assessin th realiz a ilit o defer e ta assets w conside e he i mor likel t a no tha som p o tio o al o th deferre ta asset wil no be e a ized Th ultimat realizat i o o d eferre ta asset i de e p e a tio o futur tax a b incom dur n th period i w h ic thos temp o ary difference becom ded u ctible W h e e e sa o deferre a liabilities projecte fut u taxabl i n com a n ta plannin trategie in a k n thi assessment. Beca u h c a history th ne deferre ta asse f o 2020 ha bee reduc e b a e o th amoun d e eme r e c o verabl fro th us o loss y T c u atio allow a nc wa decrease o $ 86,247 $ 92,266 th year ende Decembe 3 2022 21 v y

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Notes Payable	6. Notes Payable On August 12, 2022, the Company executed a note payable to an individual in the amount of $ 20,000 5 due date one year after execution, or the date in the which the company seems one million in total investment capital, whichever occurs first. Accrued interest as of December 31, 2022 is $ 753 On May 18, 2022, the Company executed a note payable to an individual in the amount of $ 40,000 5 due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 1,507 On February 10, 2022, the Company executed a note payable to an individual in the amount of $ 20,000 5 due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 887 On January 26, 2022, the Company executed a note payable to an individual in the amount of $ 20,000 5 due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 929 On December 1, 2021, the Company executed a note payable to an individual in the amount of $ 15,000 5 due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 812 62 On September 28, 2021, the Company executed a note payable to an individual in the amount of $ 50,000 5 due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 3,143 644 On August 4, 2021, the Company executed a note payable to an individual in the amount of $ 15,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 1,056 306 On May 10, 2021, the Company executed a note payable to an individual in the amount of $ 20,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 1,644 644 On April 15, 2021, the Company executed a note payable to an individual in the amount of $ 10,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 856 356 On March 16, 2021, the Company executed a note payable to Mr. Sergei Stetsenko, a member of our Board of Directors, in the amount of $ 15,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 1,346 596 On February 3, 2021, the Company executed a note payable to an individual in the amount of $ 10,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 400 On December 17, 2020, the Company executed a note payable to an individual in the amount of $ 19,500 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 1,987 1,012 On October 27, 2020, the Company executed a note payable to an individual in the amount of $ 10,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 1,089 590 On May 5, 2020, the Company received loan proceeds in the amount of $ 27,000 The loan matures on April 20, 2022 and bears an interest rate of 1.00% fixed per annum, 6,250 20,750 3,433 The Company has submitted the application for forgiveness of the PPP Loan in accordance with the terms of the CARES Act and are in discussions with Bank of America (the lender). During the loan forgiveness process, repayment is temporarily deferred for borrowers until the SBA remits the final loan forgiveness amount to the lender. If granted full forgiveness, Bank of America confirmed that interest and penalties would be removed along with the principal of the loan. On November 18, 2019, the Company executed a note payable to an individual in the amount of $ 50,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 1,250 6,551 4,051 On November 18, 2019, the Company executed a note payable to an individual in the amount of $ 25,000 5 due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first. 3,900 2,650

Economic Injury Disaster Loan

Economic Injury Disaster Loan	12 Months Ended
	Dec. 31, 2022
Other Income and Expenses [Abstract]
Economic Injury Disaster Loan	7. Economic Injury Disaster Loan On April 14, 2020, the Company received a grant in the amount of $ 2,000

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Employment Agreement On June 14, 2018, we entered into an employment agreement with Mr. Mannine pursuant to which he was engaged to serve as our Chief Executive Officer. The initial term of the agreement expires in June 2023, subject to successive automatic one- year renewals unless a non-renewal notice is received by either party at least 90 days prior to the expiration of the then current renewal term. Mr. Mannine’s compensation includes: · an annual base salary of $ 130,000 · an annual bonus as determined by the board of directors; · a grant of 10 100,000 0.225 · participation in all benefit plans we may offer our employees; and · 20 paid vacation days annually. Mr. Mannine's employment agreement may be terminated, and he is entitled to certain payments upon such termination, as follows: · if we should terminate Mr. Mannine’s employment without “cause” or if he should resign for “good reason" or if a “change of control” occurs, we are obligated to pay him a lump-sum severance payment equal to the sum of three months’ base salary, plus one month for every year he was employed and 50% of three years annual bonus (based on the prior year’s compensation); · if Mr. Mannine’s employment is terminated as a result of his death or disability, he is entitled to receive his base salary and a pro-rata annual bonus, if any, based on the year during which such termination is effective; or · if we should terminate Mr. Mannine for “cause,” or if he voluntarily terminates the agreement, he is entitled to receive his base salary only through the date of termination, and he is not be entitled to any other compensation for the calendar year during which the termination occurs or any subsequent calendar period, including, but not limited to, any annual bonus, if any, that has not already been paid. The employment agreement with Mr. Mannine contains customary confidentiality, non-compete and indemnification clauses. On September 21, 2020, Mr. Mannine agreed to voluntarily cancel the employment agreement. During the years ended December 31, 2022 and 2021, Mr. Mannine voluntarily agreed to waive all cash due and any related accruals. The salary forgiven for the years ended December 31, 2022 and 2021 of 130,000 130,000 Co mm tments On May 21, 2018, we entered into an Amended and Restated Strategic Financing & Corporate Development Agreement with CRG which was amended and restated an earlier agreement entered into in October 2017. We have engaged this company to serve as our non-exclusive strategic financing and corporate development services provider and to render certain advice and services to us as we may reasonably request concerning equity or debt financings, strategic planning, merger and acquisition possibilities, and business development activities. The scope of services under this agreement also includes introducing us to one or more non-U.S. persons, as that term is defined in Regulation S under the Securities Act, in connection with possible debt or equity financings or potential lenders. The initial term of the agreement expired in May 2019, but pursuant to the terms of the agreement, renews automatically for one-year periods unless notice of non-renewal is provided by either party at least 30 days prior to the renewal term commencement. The agreement was renewed until May 2022. As compensation under the terms of this agreement, we agreed to pay CRG Finance AG certain fees for transactions which are consummated during the term of the agreement and for a one year period following the termination of the agreement, including: · a fee equal to 7% of the proceeds received by us plus a warrant exercisable into 7% of the shares of our common stock at the offering price of our shares for sales by us of equity or equity-linked securities to non-U.S. Persons introduced to us by CRG Finance AG; · a fee equal to 1% of the total gross cash proceeds or non-cash consideration received by us, together with a five year warrant exercisable into 1% of the securities issued or to be issued by us in a business combination with a non-U.S. person first introduced to us by CRG Finance AG; · a fee equal to 1% of consideration received by us in any debt financing not convertible into equity, including, but not limited to, a revolving credit line or credit enhancement instrument, including on an insured or guarantee basis, with a non-U.S. Person first introduced to us by CRG Finance AG; and · a fee equal to 2% of any revenue-producing contract, fee-sharing arrangement, licensing, royalty or similar agreement with a non-U.S. Person first introduced to us by CRG Finance AG. In addition to the foregoing fees, we have agreed to reimburse CRG Finance AG for its pre-approved out of pocket expenses it incurs under the terms of the agreement. The agreement contains customary confidentiality and indemnification provisions. On February 12, 2020, we entered a consulting agreement with Primoris Group Inc (“Primoris”). Primoris was issued 200,000 common shares at a fair value of $ 45,000 0.225 100,000 Under terms of the consulting agreement, we agree to pay Primoris $ 8,000 0 96,000 Contingencies I Apri 2016 w entere int P o o oy a g e n ( h “Agreement” it consu tan t obta certai p o t ona service fr o hi (the e ” u hi nam an appeara n ce I c onsi d eratio fo th servic e r e ndere b th P rom o er w agree t us commercially re a o abl e ffort t promot an sel boo authore b hi (th “Book” an t pa hi per n h o afte d e ductio n fo al d rect cos o fulf ll n suc sale (th “R o yalty”) Durin th co u s o 2017 th Promote initiate serie o i o a a u z u e c c e e nt (“UC Lie n ” i se v e a s ate a lien a ga n s u a n c e tai o ou officers d irecto r s an founders allegin non- paymen fo th Royalt amou n t du unde th Agreement W disput th Promoter’ claim an hav determine tha a n a n al amo u t du t the Promote unde t h Agreemen hav bee pai i full W h a v s uc ceede i removin certai o t h UC Lien a n a pursuin acti o t e o the remainin unauthorize UC L e n W d n believ tha t h c l aim o th Promote a r vali i an respect.

Concentration of Credit Risk an

Concentration of Credit Risk and Major Customers and Suppliers	12 Months Ended
	Dec. 31, 2022
Risks and Uncertainties [Abstract]
Concentration of Credit Risk and Major Customers and Suppliers	9. Concentration of Credit Risk and Major Customers and Suppliers The re v enue ar co n cent r a e wit a si n l custome W purchas ou inve n or h p e n o n supplier Whil w believ tha w wil b abl t fin sec a o manufa c turin dela i t h transitio t ne s u pplie an s p e p o mater all impac ou u ines fo som per o o ime.

Stockholders_ Deficit

Stockholders’ Deficit	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Stockholders’ Deficit	10. Stockholders’ Deficit Ou authori z e c apita toc c onsist o 50,000,000 h are o commo stock pa v a u $ 0.0001 pe share an 5,000,000 share o blan chec preferred toc k pa v a u $ 0.0001 pe share A o Decembe 3 2022 an h 11,599,830 11,599,830 share o comm c u respe c ivel an ther are no sh a e o pr e e re stoc ssue an outstandin a eith e date. Contributed Capital On September 21, 2020, Mr. Mannine voluntarily agreed to cancel his employment agreement and waive all cash due and any related accruals. The salary forgiven for the year ended December 31, 2022 and 2021 of 130,000 130,000 is treated as in-kind contribution of service and reflected as contributed capital in the financial statements (See notes 4 and 8). During the year ended December 31, 2020, Mr. Mannine personally paid $3,040 of company expenses. This is reflected as contributed capital in the financial statements. Consulting Agreement On February 12, 2020, we entered a consulting agreement with Primoris Group Inc (“Primoris”). Primoris was issued 200,000 common shares at a fair value of $45,000 ($0.225 per share) on June 30, 2020. 100,000 shares are restricted from resale or transfer by Primoris per the consulting agreement until February 12, 2021. The consultant has an option to register 100,000 on any future registration statement. In addition to any restrictions imposed by the agreement, all the shares require an exemption for resale to the public. The agreement was not renewed upon expiration date. Preferre d S o c Ou boar o directors withou f urthe stoc k holde ap p o al a issu prefe re stoc on o serie fro ti t i a n fi o alte the des gna ions relat v rights pr o it es p e e ences quali ications limit a ion an e stric ion o th share o eac se r ies Th right pref e r e nces limit a ions an estr c ion o differen serie o prefer e stoc ma d ffe wit respec t dividen ra o a u a tion v o in rig h ts c o nversio rights, d e o k f un provisi o a n othe matter a c a u th o iz t h issuanc o pre e r e stock whic a nk senio to ou commo stoc f o th p aymen v e n t io o asset o liquidation I o a c o r ca i imi ation a nd restri c ions i a n upo th pa d b a sse o ou commo stoc t b e ffectiv whil an share o p eferre st o c a outstanding. Warrants O Oct o e 1 0 2017 w entere h F n n i t C G a mor full esc ibe i Not 4 and 8 In connection with the related equity financing as of December 31, 2017, CRG had earned 368,111 0.225 34,405 45 2.2 5 Durin Januar 2018 a par o th P rivat Placemen mor full describe i Not 4 CR earne a additio n a 17,655 full ve c o n wit a ex e cis pric o $ 0.225 These additional warrants were issued to CRG on January 30, 2018. We determined that the warrant had an initial fair value of $ 1,670 0.225 45 2.51 5 On Marc 8 2018 w en ere in a advisor agreemen wit sci e ntifi a d iso t provid ce r tai service t us Pursua n t th agreement w issued 100,000 five-ye a commo sto c w rrant a a e x ercis pric o $ 0.90 S u c warrant v e s subjec t c er i iles o s A e 1 100,000 100,000 thes warrant hav vested W d e rmi a h warra a a o $ 1,905 We estimated the fair value of this warrant using the Black- Scholes option pricing model, based on the following assumptions: the recent cash offering price of $ 0.225 45 2.63 5 As of December 31, 2022 and December 31, 2021, the intrinsic value for warrants outstanding and exercisable is $ 19,288 28,932 Th followin tabl summ a ize n o matio a bou th w a ra n outsta n din a o Decembe 31 2 022 an 2021: Warrants Earned and Outstanding 2022 2021 Warrants Weighted Average Exercise Price Warrants Weighted Average Exercise Price Outstanding, beginning of year 485,766 $ 0.364 485,766 $ 0.364 Granted — — — — Exercised — — — — Forfeited — — — — Expired — — — — Outstanding, end of year 485,766 $ 0.364 485,766 $ 0.364 Exercisable, end of year 485,766 $ 0.364 485,766 $ 0.364 As of December 31, 2022 Warrants Outstanding and Exercisable by Range of Exercise Price Warrants Outstanding Warrants Exercisable Range of Exercise Price Number Outstanding Remaining Average Contractual Life (In Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.225 0.90 485,766 .61 $0.364 485,766 $0.364 As of December 31, 2021 Warrants Outstanding Warrants Exercisable Range of Exercise Price Number Outstanding Remaining Average Contractual Life (In Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.225 0.90 485,766 1.10 $0.364 485,766 $0.364

Stock Option Plan

Stock Option Plan	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock Option Plan	11. Stock Option Plan In Decembe 201 ou b oar o di r ecto ado p te ou 201 E q uit Incenti v Plan o th “201 P l an. Ou stoc k holder ratifie 0 P e b 2017 Th purpos o th 201 Pla i t en c ourag ow n er h i o n u e d rectors employee an consult nts an t incenti v z and a ig h interes o th pla par icipant wi th terest st h e s W h a e e v e 1,100,000 u commo sto c fo issua n c u nder th 201 Plan Grant p r u an t th 201 Pla ma be i incentiv toc options ii non-sta u or stoc options iii st oc a ards includin share o our c m o st c a s oc u ts an iv stoc appreciati o right s Th boar o director o committ e o t h b o a o di e c tor admi n ister th 201 Plan Pre s e n tly th 201 Pla i admini s tere b ou b o ar o dire c ors. e a p th manne i whic i ma b exercise i determine b th boar o director o c o mitte o th boar o d rectors, o d o e e rcis a l mor tha 1 year afte t h d a o it gran and i th cas o a ince n tiv opt o n a b ow n n mor tha 1 0 o th commo st o k n mor tha fiv y e a r afte th dat o h ran T term o grant o an othe d a n b d irector o committe o th boar o director a th tim o grant T 201 Pla provi d e tha th maxim u valu o a n awar durin an calenda y a c 0 An optio grante u nde th pla mus provid fo a exerci pric o no les t h a 1 00 o t h a i mark e valu o th und n a h a gr a t bu th exerci pric o a e n Pla t a eligibl empl o ye ow n n mor tha 10 o ou o u s t andin commo toc must no b les tha 110 o fai mar u g ra n T 201 Pla f u the provide tha wit respe c t ISO th aggreg a fai marke valu of th commo st o c u nderl y n th optio n whic ar exercisabl a n p a parti c pa n durin a e y n e e $ 100,000 Opti o award may o d e e n o cash c o s e e v e b u und e broker-assiste al an remittanc program cashles e ercise an ot h e consideratio legall permitted o combi n atio o th forego T a m inistr a o ma als determin th metho o paymen o th e ercise pric a th tim th optio i bein exerci e d Gr a nt unde t h 2 0 1 P a ar no transferrable. Ge n er a lly option whic ar exerci ab a th dat o th p a pa tic p ant e minat o fro o employmen o severan c o h relat ns w t compan mus b exercise wit h i thre mon h o th te minati da e pla admin strato ma exten th ex e cis peri o o th o tio fo separated pla partici p an providin th a h x d e d a e b eyon th o igina e x iratio da h p S e n erall optio n w i a exerci a bl a th dat o th p p a deat mus b e x ercise w thi s month th term n a io at i th e ven o t h disabilit of th pla participan o 1 month follow i n th pla particip a nt’ death I ou discreti o n a n n p b pla par icipan term n a e for caus ma b imme d atel cancell e d. I th even ther i “chang i o o a a define i th 201 Plan a determine b th b ar o direct o o th committee w m a in ou discretio n i provid f o th a s u p io o substitutio of o a d justmen (includin t th n umbe an typ o sh a e an exercis o purch a s price b o a n c h e t in o option an terminat a n restriction o stoc awards and/o iii provid f o termination o award a resul o th cha c o an c ondition a i de e appropri n p v t h cancellatio o aw a d fo cas o othe p aymen t rt c n Th numbe o share o o u commo sto c u n derlyin an outstandin bu une x ercise optio an th ex e cis pric o th a opt o p o u o s p it stoc combinations dividends a n simila c rporat ev e ts. O Jun 14 2 0 18 purs n t em o m n agreemen wit Mr M a nnine mor full d escribe i Not 8 w issue 100,000 st c optio n wit an exerci pric o $ 0.225 Suc o v es upo t h effectivenes o regi tratio state e o For S -1 W determ e tha th opt o n a a ini ial v u 13,221 W e s e th fai valu o thes op t io n usin th Bla c k-Schole o ptio pricin model b a e o th o low n assumptions the re c en cas offerin pric o $0.22 a th estimate fai val o th underlyin c mm o stoc a th valuatio measuremen d ate n di v de n y iel f o al of th years e x ecte volatilit 45 r sk-fre interes rat o 2.2 a n a e x ecte lif o 10 years W amortize th fai valu o ve th perio fro their c 2 u e b 0 whic th registratio statemen wa d ecla e effective As of December 31, 2022 and December 31, 2021, the intrinsic value for option outstanding and exercisable is $ 5,000 7,500 Th followin tabl summ a ize n o matio a bou stoc opti o n o u tstandin an exercisabl a a o Dec e m b e 31 2022 an 2 Options outstanding and exercisable 2022 2021 Options Weighted Average Exercise Price Options Weighted Average Exercise Price Outstanding, beginning of year 100,000 $ 0.225 100,000 $ 0.225 Granted — — — — Exercised — — — — Forfeited — — — — Expired — — — — Outstanding, end of year 100,000 $ 0.225 100,000 $ 0.225 Exercisable, end of year 100,000 $ 0.225 100,000 $ 0.225 Options available for future grant, end of year 1,000,000 1,000,000 As of December 31, 2022 Options outstanding by exercise price range Options Outstanding Options Exercisable Range of Exercise Price Number Outstanding Remaining Average Contractual Life (In Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.225 100,000 6.44 $0.225 100,000 $0.225 As of December 31, 2021 Options Outstanding Options Exercisable Range of Exercise Price Number Outstanding Remaining Average Contractual Life (In Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.225 100,000 6.93 $0.225 100,000 $0.225

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	12. Subsequent Events On March 1, 2023, the company executed a note payable to an individual in the amount of $ 60,000 5

Summary of Critical Accountin_2

Summary of Critical Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounting Principles	Accounting Principles The financial statements and accompanying notes are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Use of Accounting Estimates	Use of Accounting Estimates The preparati o a a tement i conformit wit U.S GAA requ re a nagemen t mak cer ai est mate an assumption tha aff e c the re p rte amount o asset a n liabilitie an di c losur o cont gen asset an liab li ie a th dat o h financia s t atement an th re p rte amount of re v enu an expense durin th reporti n p e iod W believ t a judg e me n i involve n ou reserv fo refunds o holdb a ck reserv e o stock-base compe sation. W evaluat o u estimates an as u m p tion a fact a n c rcumstance di c tate A utur event a n thei e fect canno b e p e c tua result c oul diffe from thes estimate an assum p tions a n thos differen c e co u b ma e ia t h F anc a Sta e en s.
Cash	Cash C as nc u e c a an dep o ite a on are ban an ma excee federall insure limit a n s i ghl liqui investment wit t ri re m t o les whe purchase t b c as e q u v a e n s T car y am n e porte i th balanc sheet o cas an cas equivalents approximat thei fai value.
Holdback Receivable	Holdback Receivable Holdba c receiva b include m rchan holdbac ne o e e r v fo r e urns whic reser v i $ 58 $ 58 a c e b e 31 2022 an 2021, es p ectively.
Revenue Recognition	Revenue Recognition The Company accounts for revenue in accordance with Accounting Standard Codification (“ASC”) We generate revenues primarily from (i) internet content subscriptions and (ii) sales of nutritional supplements. Revenues are recognized upon the acceptance of subscription membership or shipment of nutritional supplements, provided that an order has been received or a contract executed, there are no uncertainties regarding customer acceptance, the sales price is fixed or determinable and collection is deemed reasonably assured. If uncertainties regarding customer acceptance exist, we recognize revenues when those uncertainties are resolved, and title has been transferred to the customer. Amounts collected or billed prior to satisfying the above revenue recognition criteria are recorded as deferred revenue. Ou percentage o rev e nu b typ fo y ear en d e Decemb e 31 2 022 an 2021 ar a follows: Percentage of Revenue by Type Year ended December 31, 2022 2021 Internet content subscriptions 0.0 % 0.0 % Nutritional supplements 100.0 % 100.0 %
Shipping and Handling Costs	Shipping and Handling Costs We include shipping and handling fees billed to customers as revenue and shipping and handling costs for shipments to customers as cost of revenue.
Loss Per Share	Loss Per Share Basi los pe c o mo shar compute b di v din ne los b th weighted-averag numbe o commo share o utstandin durin th period Dilute loss pe commo shar i base upo t weighted-avera g commo share out tan d n durin t h perio plu a d itiona weighted-aver g commo equivalent h are outstandin duri n th per o Commo eq u iv a en share resul fro th assume exerci d n an warrants th proce e d of whic ar the assume t h a b ee use t repurchas outst a d n o n a u e o a th numerato i a d juste for an change i incom (loss th a o u resul fro th assume c onversio o potenti a shares Potentiall dilutiv h ares h c wer e cl u e ro t h d lute s pe sha calculat o be c aus th effec woul b a o n w arrant ex e cis pric e wer g e a te t h a th averag market pric o th commo shares wer 585,766 s a f t r e nde D e cembe 3 1 2022 an 2021.
Income Taxes	Income Taxes Th provisio fo inc o taxe i nc u d e federal stat e l o ca an foreig taxes In c om taxe ar a ccounte fo un d e th liabi it ethod e erre ta a sets an liabiliti e ar r e cognize fo th estimate futur ta co n e quence o temporar differen c e betwee t h financia statemen carryin amount an their es p ec iv ta b ases. Deferre t a asset a n liabilitie ar me a u e usin enacte ta rate expecte t ap p t t axa b l incom i t y i hic th temporar di feren c e are expecte t b recovere o se tled W evaluat t h realizabi it o ou deferr e ta asset a n establis va u o an c whe i i mor likel tha not a a o port o deferre ta asset wi no b rea ize d W accoun f o unc e tai ta posi ion usin “more-li k ely-tha h e h c n a n resolvin uncertai ta positions T evaluatio of uncertai ta position i base c n d g o imi e to change i a law h measuremen o ta posi io k e o e a returns h effectiv sett e e n o matter subjec t audit ne aud ac ivit an change i fact o circ u mstance re a W v u a thi ta positio o quart e l basis W al ac c fo pot e n ia interes an pena ties applicable re a e t u nrecog b t i incom tax expense.
Stock-Based Compensation	Stock-Based Compensation We account for stock based instruments issued to employees and non-employees for services in accordance with Accounting Standard Codification (“ASC”) Topic 718. St o ck-base compensatio i me a s e a e v u h awar an i recognize a a e xpens ove th requisite e v Accordingly th Black-Sch o e opti o pricin m o de i utilize t d e riv a estimate fai v u e Th Black- S chole pricin mo d e require th consideratio o h foll o win si variable fo purpose o estimatin f a i val u e: · the stock option exercise price; · the expected term of the option; · the grant date price of our common stock, which is issuable upon exercise of the option; · the expected volatility of our common stock; · the expected dividends on our common stock (we do not anticipate paying dividends in the foreseeable future); and · the risk-free interest rate for the expected option term. Expe c ed Di v ide n ds W hav nev e declare o p a i an cas divi d end o a n o ou capita s c n i th foresee a b future. Acc o d in g y w us a expecte divid e n y el o z e t c al cu at h ran - at a valu o stoc option. Expe c ed Volatility Th expecte volatilit i m e asur o t h u o p i c i exp e cte t luctuat dur n th expecte ter o o ptions g a t e d W determin th expec t e volatilit solel base up o th hi torica o ati it ou comm o stoc ove p erio c o mmensurat wit th opti o n’s expecte term W d no belie v tha th futu volati it ou comm o stoc ove a option’ expecte te i lik e t diffe signif c a n l f th pas Risk-Free Interest Rate . Th risk- re in e es a i th m li e yiel availa b l o U.S reasur zero-coupo issue wit remainin ter equ a t the option’ expecte te o t h gra n date. Expe c ed Term F o optio grant subseq u n t th ado p tio o th fai valu re c ognitio provis o h c n rds th expe c e lif o stock option grante i base o t h actua vestin dat an th en o th co n ractua term. Gr a Date Price of Common S o c h a e c o h a g a n
Fair Value of Financial Instruments	Fair Value of Financial Instruments W o llo Acco u tin Standard Co d ficatio 82 0 - 1 (“AS 8 20-1 0 “Fai r V a lu Measur e e n t an Disclosures, fo a valu measurements AS 8 2 0- 1 d efine fai value establis h e fr a e or fo measurin f i value an exp a nd d isclosu r e a bou fai v a lu measurements T h standar provide consi ten def it o fa value whic f o cuse o a exi price whic i t h p r ic th a woul b receive t sel a asse o pai t t a n s e liabilit i an d e a etw a k e rt ipant a th mea u e m e n date T h standar als p ioritizes withi t h measuremen o fai alue h us of mark e -base inform a tio ove en t it p ecifi informati o a n e stabli h e three-le v e hierarch f o fai valu m e asuremen base o th n at u o in p ts h a a e o l ab l t a o th mea u r e e n date. Th hierarch establishe unde A S 820-1 give th highes priorit t u n adjuste qu o te pri v d i ca asset o liabilitie (Leve 1) an th lowes pri o it t unobserv a bl input (Leve 3) Th hre level o t h fai v a u hierarch unde A S 820-1 ar de e e Leve Pri c in input ar quo t e price a v ailabl i activ market o ident ca n ves ment h o e require b AS 8 20-10 we d n adjus th quote pric f o thes investm e nts e ve i s t ati w er w h a g o it o an sal c o reas n a bl impac th quoted Leve Pri c in input ar quo t e price fo simila i n estme n s o i n put tha ar observable eithe d rectl ind rec ly fo subs an ial th ll ter throu g c o rro b or a io wit observabl marke data Le v e nc de investment value a q uot e price adjuste fo leg a o r t estri c ion speci i t s n s m ts Leve Pri c in input ar uno b ser v abl fo th investment t a s i u h a ref c h re rti e it ’ w ass m i on abou t h assumptions mark e participant wo u us i pric n th asse o iabil t Leve include inv e tment a o a c y The carrying a u o sh holdbac receivable prepaid expense and other current asset, ac c ount pa y abl an ac c e e x ense approx i mat thei fai value du to thei s h ort-ter matu iti e a o Decembe 31 2 022 a n 2 021.
Recent Accounting Pronouncements	Recent Accounting Pronouncements We have evaluated all issued but not yet effective accounting pronouncements and determined that, other than the following, they are either immaterial or not relevant to us.

Summary of Critical Accountin_3

Summary of Critical Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Percentage of Revenue by Type	Percentage of Revenue by Type Year ended December 31, 2022 2021 Internet content subscriptions 0.0 % 0.0 % Nutritional supplements 100.0 % 100.0 %

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Tax Rate Reconciliation	Income Tax Rate Reconciliation 2022 2021 Tax Rate Tax Rate Taxes computed at statutory rate Federal $ (57,117 ) 21.00 % $ (57,032 ) 21.00 % State (9,160 ) 3.95 % (10,727 ) 3.95 % Total taxes at blended statutory rate $ (66,277 ) 24.95 % $ (67,759 ) 24.95 % Increase (decrease) resulting from: Effect of tax rate change — 0.00 % — 0.00 % Nondeductible expenses 31,581 0.00 % — 0.00 % State income tax refund — 0.00 % — 0.00 % Other — -0.14 % 385 -0.14 % Change in valuation allowance 36,336 -24.81 % 67,374 -24.81 % Total income tax (benefit) expense $ 1,640 -0.00 % $ (0 ) -0.00 %
Deferred Tax Assets and Liabilities	Deferred Tax Assets and Liabilities 2022 2021 Deferred tax assets: Net operating loss carryforward $ 423,025 $ 509,707 Amortization of intangibles 7,936 7,485 Reserve for refunds 0 15 Stock compensation 3,774 3,774 Charitable contribution carryforward 3,355 3,355 Total deferred tax assets 438,090 524,337 Less: Valuation allowance (438,090 ) (524,337 ) Net deferred tax assets $ — $ —

Stockholders_ Deficit (Tables)

Stockholders’ Deficit (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Warrants Earned and Outstanding	Warrants Earned and Outstanding 2022 2021 Warrants Weighted Average Exercise Price Warrants Weighted Average Exercise Price Outstanding, beginning of year 485,766 $ 0.364 485,766 $ 0.364 Granted — — — — Exercised — — — — Forfeited — — — — Expired — — — — Outstanding, end of year 485,766 $ 0.364 485,766 $ 0.364 Exercisable, end of year 485,766 $ 0.364 485,766 $ 0.364
Warrants Outstanding and Exercisable by Range of Exercise Price	Warrants Outstanding and Exercisable by Range of Exercise Price Warrants Outstanding Warrants Exercisable Range of Exercise Price Number Outstanding Remaining Average Contractual Life (In Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.225 0.90 485,766 .61 $0.364 485,766 $0.364 As of December 31, 2021 Warrants Outstanding Warrants Exercisable Range of Exercise Price Number Outstanding Remaining Average Contractual Life (In Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.225 0.90 485,766 1.10 $0.364 485,766 $0.364

Stock Option Plan (Tables)

Stock Option Plan (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Options outstanding and exercisable	Options outstanding and exercisable 2022 2021 Options Weighted Average Exercise Price Options Weighted Average Exercise Price Outstanding, beginning of year 100,000 $ 0.225 100,000 $ 0.225 Granted — — — — Exercised — — — — Forfeited — — — — Expired — — — — Outstanding, end of year 100,000 $ 0.225 100,000 $ 0.225 Exercisable, end of year 100,000 $ 0.225 100,000 $ 0.225 Options available for future grant, end of year 1,000,000 1,000,000
Options outstanding by exercise price range	Options outstanding by exercise price range Options Outstanding Options Exercisable Range of Exercise Price Number Outstanding Remaining Average Contractual Life (In Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.225 100,000 6.44 $0.225 100,000 $0.225 As of December 31, 2021 Options Outstanding Options Exercisable Range of Exercise Price Number Outstanding Remaining Average Contractual Life (In Years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.225 100,000 6.93 $0.225 100,000 $0.225

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 273,623	$ 271,581
Working Capital Deficit	635,489
Accumulated deficit	2,260,901	1,987,278
Net cash used in operations	123,692	130,513
Holdback Receivable from merchant, net of reserve for refunds	$ 15,764	$ 15,764

Summary of Significant Accounti

Summary of Significant Accounting Policies (Percentage of Revenue by Type) (Details) - Revenue, Product and Service Benchmark [Member]	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Internet Content Subscriptions [Member]
Product Information [Line Items]
Concentration Risk, Percentage	0%	0%
Nutritional Supplements [Member]
Product Information [Line Items]
Concentration Risk, Percentage	100%	100%

Summary of Critical Accountin_4

Summary of Critical Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Refunds	$ 58	$ 58
Potentially dilutive shares	585,766	585,766

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)		1 Months Ended		12 Months Ended
	Jun. 14, 2018	May 18, 2022	Mar. 16, 2021	Dec. 31, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Options issued
Exercise price
In-kind Contribution of Service				$ 130,000	$ 130,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Expected term	10 years
Options issued	100,000
Exercise price	$ 0.225
Note Payable [Member]
Related Party Transaction [Line Items]
Note payable		$ 40,000
Interest rate		5%
Term		due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.
Note Payable [Member] | Mr Sergei Stetsenko [Member]
Related Party Transaction [Line Items]
Note payable			$ 15,000
Interest rate			5%
Term			due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.
Accrued interest				$ 1,336

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Federal	$ (57,117)	$ (57,032)
Federal	21%	21%
State	$ (9,160)	$ (10,727)
State	3.95%	3.95%
Total taxes at blended statutory rate	$ (66,277)	$ (67,759)
Total taxes at blended statutory rate	24.95%	24.95%
Effect of tax rate change
Effect of tax rate change	0%	0%
Nondeductible expenses	$ 31,581
Nondeductible expenses	0%	0%
State income tax refund
State income tax refund	0%	0%
Other		$ 385
Other	(0.14%)	(0.14%)
Change in valuation allowance	$ 36,336	$ 67,374
Change in valuation allowance	(24.81%)	(24.81%)
Total income tax (benefit) expense	$ 1,640	$ 0
Total income tax (benefit) expense	(0.00%)	(0.00%)

Income Taxes (Details - Income

Income Taxes (Details - Income Tax Rate Reconciliation) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Net operating loss carryforward	$ 423,025	$ 509,707
Amortization of intangibles	7,936	7,485
Reserve for refunds	0	15
Stock compensation	3,774	3,774
Charitable contribution carryforward	3,355	3,355
Total deferred tax assets	438,090	524,337
Less: Valuation allowance	(438,090)	(524,337)
Net deferred tax assets

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 2,505	$ 0
Net operating loss carryforwards	$ 1,800,000
Income taxes description	Net operating losses of approximately $1.39 million may be carried forward indefinitely subject to limitation. Net operating losses of approximately $407,000 will begin expiring in 2037. Income taxes amounted to less than the amounts computed by applying the U.S. Federal income tax rate of 21% to income (loss) before income taxes.
Valuation allowance	$ 86,247	$ 92,266

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)

1 Months Ended

Aug. 12, 2022

Feb. 10, 2022

Oct. 04, 2021

Aug. 04, 2021

May 10, 2021

Apr. 15, 2021

Mar. 16, 2021

Feb. 03, 2021

Dec. 17, 2020

May 05, 2020

Nov. 18, 2019

May 18, 2022

Jan. 26, 2022

Dec. 01, 2021

Sep. 28, 2021

Sep. 15, 2021

Oct. 27, 2020

Dec. 31, 2022

Dec. 31, 2021

Nov. 19, 2021

May 14, 2020

Short-Term Debt [Line Items]

PPP Courtesy Credit

$ 6,250

Note Payable A [Member]

Short-Term Debt [Line Items]

Note payable

$ 20,000

Interest rate

5%

Term

due date one year after execution, or the date in the which the company seems one million in total investment capital, whichever occurs first.

Accrued interest

$ 753

Note Payable [Member]

Short-Term Debt [Line Items]

Note payable

$ 40,000

Interest rate

5%

Term

due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Note Payable 1 [Member]

Short-Term Debt [Line Items]

Accrued interest

1,507

Note Payable One [Member]

Short-Term Debt [Line Items]

Note payable

$ 20,000

Interest rate

5%

Term

due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

887

Note Payable Two [Member]

Short-Term Debt [Line Items]

Note payable

$ 20,000

Interest rate

5%

Term

due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

929

Note Payable Three [Member]

Short-Term Debt [Line Items]

Note payable

$ 15,000

Interest rate

5%

Term

due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

812

$ 62

Note Payable Four [Member]

Short-Term Debt [Line Items]

Note payable

$ 50,000

Interest rate

5%

Term

due after one year of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

3,143

644

Note Payable Five [Member]

Short-Term Debt [Line Items]

Note payable

$ 15,000

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

1,056

306

Note Payable Six [Member]

Short-Term Debt [Line Items]

Note payable

$ 20,000

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

1,644

644

Note Payable Seven [Member]

Short-Term Debt [Line Items]

Note payable

$ 10,000

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

856

356

Note Payable Eight [Member]

Short-Term Debt [Line Items]

Note payable

$ 15,000

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

1,346

596

Note Payable Nine [Member]

Short-Term Debt [Line Items]

Note payable

$ 10,000

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

$ 400

Note Payable Ten [Member]

Short-Term Debt [Line Items]

Note payable

$ 19,500

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

1,987

1,012

Note Payable Eleven [Member]

Short-Term Debt [Line Items]

Note payable

$ 10,000

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

1,089

590

P P P Loan [Member]

Short-Term Debt [Line Items]

Note payable

20,750

20,750

Term

The loan matures on April 20, 2022 and bears an interest rate of 1.00% fixed per annum,

Proceeds from Loans

$ 27,000

Debt Instrument, Periodic Payment

$ 3,433

Note Payable Twelve [Member]

Short-Term Debt [Line Items]

Note payable

$ 50,000

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

6,551

4,051

$ 1,250

Note Payable Thirteen [Member]

Short-Term Debt [Line Items]

Note payable

$ 25,000

Interest rate

5%

Term

due after six months of execution, or the date in which the Company secures one million dollars in total investment capital, whichever occurs first.

Accrued interest

$ 3,900

$ 2,650

Economic Injury Disaster Loan (

Economic Injury Disaster Loan (Details Narrative)	Apr. 14, 2020 USD ($)
Other Income and Expenses [Abstract]
Other income	$ 2,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)			12 Months Ended
	Feb. 12, 2020	Jun. 14, 2018	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Options issued
Exercise price
In-kind Contribution of Service			$ 130,000	$ 130,000
Payable in advance				15,000
Primoris Group Inc [Member]
Defined Benefit Plan Disclosure [Line Items]
Vested	$ 45,000
Offering price	$ 0.225
Payable in advance			8,000
Accrued expense			$ 0	$ 96,000
Primoris Group Inc [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares restricted	100,000
Chief Executive Officer [Member]
Defined Benefit Plan Disclosure [Line Items]
Annual base salary		$ 130,000
Expected life		10 years
Options issued		100,000
Exercise price		$ 0.225

Stockholders' Equity (Informati

Stockholders' Equity (Information About Warrants Earned and Outstanding) (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning of period	485,766	485,766
Weighted average exercise price outstanding, beginning of period	$ 0.364	$ 0.364
Granted
Weighted average exercise price, Granted
Exercised
Weighted average exercise price, Exercised
Forfeited
Weighted average exercise price, Forfeited
Expired
Weighted average exercise price, Expired
Outstanding, end of period	485,766	485,766
Weighted average exercise price outstanding, end of period	$ 0.364	$ 0.364
Exercisable, end of period	485,766	485,766
Weighted average exercise price exercisable, end of period	$ 0.364	$ 0.364

Stockholders' Equity (Warrants

Stockholders' Equity (Warrants Outstanding by Price Range) (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Range of exercise price, lower limit	$ 0.225	$ 0.225
Range of exercise price, upper limit	$ 0.90	$ 0.90
Number outstanding	485,766	485,766
Remaining Average Contractual Life	7 months 9 days	1 year 1 month 6 days
Weighted Average Exercise Price, Outstanding	$ 0.364	$ 0.364
Number exercisable	485,766	485,766
Weighted average exercise price, exercisable	$ 0.364	$ 0.364

Stockholders_ Deficit (Details

Stockholders’ Deficit (Details Narrative) - USD ($)			1 Months Ended	12 Months Ended
	Mar. 08, 2018	Oct. 10, 2017	Jan. 31, 2018	Dec. 31, 2022	Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Common stock, shares authorized				50,000,000	50,000,000
Common stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares authorized				5,000,000	5,000,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Common stock, shares issued				11,599,830	11,599,830
Common stock, shares outstanding				11,599,830	11,599,830
Preferred stock, share issued				0	0
Preferred stock, shares outstanding				0	0
In-kind Contribution of Service				$ 130,000	$ 130,000
Intrinsic value for warrants outstanding				$ 19,288	$ 28,932
C R G Finance A G [Member] | Warrant [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Issued		368,111	17,655
Exercise price		$ 0.225	$ 0.225
Fair value		$ 34,405	$ 1,670
Volatility		45%	45%
Risk free interest rate		2.20%	2.51%
Expected life		5 years	5 years
Offering price			$ 0.225
Scientific Advisor [Member] | Warrant [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Issued	100,000
Exercise price	$ 0.90
Fair value	$ 1,905
Volatility	45%
Risk free interest rate	2.63%
Expected life	5 years
Offering price	$ 0.225
Vested				100,000	100,000

Stock Option Plan (Stock Option

Stock Option Plan (Stock Options Outstanding) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]
Options outstanding, beginning of period	100,000	100,000
Weighted average exercise price outstanding, beginning of period	$ 0.225	$ 0.225
Options outstanding, Granted
Weighted average exercise price, Granted
Options outstanding, Exercised
Weighted average exercise price, Exercised
Options outstanding, Forfeited
Weighted average exercise price, Forfeited
Options outstanding, Expired
Weighted average exercise price, Expired
Options outstanding, end of period	100,000	100,000
Weighted average exercise price outstanding, end of period	$ 0.225	$ 0.225
Options outstanding Exercisable, end of period	100,000	100,000
Weighted average exercise price, Exercisable end of period	$ 0.225	$ 0.225
Options available for grant	1,000,000	1,000,000

Stock Option Plan (Stock Opti_2

Stock Option Plan (Stock Options Outstanding by Exercise Price) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]
Range of Exercise Price, upper	$ 0.225	$ 0.225
Number Outstanding	100,000	100,000
Remaining Average Contractual Life	6 years 5 months 8 days	6 years 11 months 4 days
Weighted Average Exercise Price	$ 0.225	$ 0.225
Number Exercisable	100,000	100,000
Exercisable Weighted Average Exercise Price	$ 0.225	$ 0.225

Stock Option Plan (Details Narr

Stock Option Plan (Details Narrative) - USD ($)		12 Months Ended
	Jun. 14, 2018	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized		1,100,000
Options issued
Exercise price
Intrinsic value		$ 5,000	$ 7,500
Chief Executive Officer [Member]
Defined Benefit Plan Disclosure [Line Items]
Options issued	100,000
Exercise price	$ 0.225
Options fair value	$ 13,221
Expected volatility	45%
Risk free rate	2.20%
Expected term	10 years

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent Event [Member]	Mar. 01, 2023 USD ($)
Subsequent Event [Line Items]
Note payable	$ 60,000
Interest rate	5%